A male doctor in a white coat and stethoscope.

Wait, before you go!

Subscribe to get important updates and helpful insights delivered straight to your inbox.

Thank you! We received your submission!
Oops! Something went wrong
Our Team
Technology
pipeline
News & Updates
CONTACT
Published
January 25, 2021

SMSbiotech Completes Clinical Test for Chronic Non-Healing Wound Product

Company News
Other Indications
SMSbiotech Completes Clinical Test for Chronic Non-Healing Wound Product

SMSbiotech is pleased to announce the successful completion of the HRIPT clinical test for its wound regeneration product, which is designated for chronic, non-healing wounds.

This clinical test was conducted by Eurofins Scientific on 50 volunteers. The second clinical test will be conducted shortly.

Resources

No items found.
Published on:
19 Sep 2023
Copy link
This is some text inside of a div block.
Back to Lobby
Dr. Joseph Loewenbein, M.D. Joins SMSbiotech as Scientific Advisor
Next Article
12th Annual World Patient Safety, Science & Technology Summit
Next Article
Joe Kiani Appointed Chairman of the Board at SMSbiotech
Next Article
Novel Cell Sources in Cell Therapy: Overcoming Scalability and Safety Limits | Advanced Therapies Week 2026
Next Article
SMSbiotech Advancing Regenerative Therapies for Orthopedics
Next Article
Embed Audio and Video files in Blog Post
Next Article
Breakthrough in Angiogenesis: Small Mobile Stem Cells Drive Large Vessel Formation
Next Article
From Conflict to Discovery: How Abdulkader Rahmo, PhD, is Shaping Stem Cell Research
Next Article
Revolutionizing COPD Treatment: Inhaled Small Mobile Stem Cells for Lung Regeneration
Next Article
Revolutionizing Regenerative Medicine: The Potential of Small Mobile Stem (SMS) Cells
Next Article
A Breakthrough in COPD Regeneration: How Small Mobile Stem (SMS) Cells Transform Lung Repair
Next Article
SMS Cells After RF Microneedling: New Evidence Shows Faster Recovery & Better Skin Quality
Next Article
A New Era in Veterinary Regenerative Medicine: How SMS Cells Are Transforming Animal Health
Next Article
SMSbiotech Announces Successful Presentation of Small Mobile Stem Cell Regenerative Mechanism in Human COPD Patients at ERS LSC 2025
Next Article
SMSbiotech Featured in News for COPD Therapy
Next Article
SMSbiotech Founder Featured on “HealthTech CEO Wisdom” Podcast
Next Article
SMSbiotech Visits Tijuana EDC to Explore Clinical Opportunities
Next Article
SMSbiotech Founder Discusses Inhaled Stem Cell Therapy for COPD in MIA Interview
Next Article
European Society of Medicine Publishes Groundbreaking Article on Small Mobile Stem Cells
Next Article
SMSbiotech Expands with New San Diego Bio-Manufacturing Facility
Next Article
Regenerative Breakthrough in Canine Wound Healing
Next Article
Early Results Demonstrate Safety and Progress in SMSbiotech’s Human COPD Study
Next Article
Breakthrough Study in Horses Reinforces SMS Cell Therapy’s Platform Versatility
Next Article
Dr. Rahmo Showcases SMSbiotech’s Breakthrough Cell Therapy at Biotech Global Summit.
Next Article
SMSbiotech Welcomes New Advisor Steven N. Copp, MD
Next Article
Milestone Achievement: First COPD Patient Dosed in Phase 1 Trial
Next Article
SMSbiotech Secures New Japanese Patent
Next Article
Newsweek: The New Era of Life Sciences 2025
Next Article
Discover Breakthrough COPD & Regenerative Medicine Insights at RIS 2025
Next Article
SMSbiotech Establishes a CRADA with the U.S. Army Medical Research Institute of Chemical Defense
Next Article
9th Edition: Aging & Gerontology Event
Next Article
SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD
Next Article
Drug Discovery Innovation Programme 2025
Next Article
SMSbiotech Welcomes New Board of Advisor Member Dr. Jason P. Kirkness
Next Article
A New Era of Healing: Our Latest Patent is Here!
Next Article
SMSbiotech Receives New European Patent!
Next Article
American Thoracic Society 2024 Respiratory Innovation Summit
Next Article
VIP Speaker at 7th Alcor Drug Discovery Platform
Next Article
12th Annual Drug Discovery Strategic Summit
Next Article
5th Annual Age-Related Disease Therapeutics Summit
Next Article
Biocom Global Life Science Partnering & Investor Conference
Next Article
Unveiling Hope: A Potential Breakthrough Treatment for COPD from SMSbiotech
Next Article
6th Annual CGTI Leaders Summit 2023
Next Article
SMSbiotech Unveils New Patented Stem-Cell Technology Designed to Treat COPD
Next Article
Cell Symposia: Advances in Therapeutic Applications of Stem Cells
Next Article
10th International Conference on COPD and Lung Health
Next Article
Patent Application Accepted
Next Article
6th Annual IPF Summit 2022
Next Article
4th Annual Longevity Therapeutics Summit
Next Article
Voice of America - Innovations
Next Article
SMSbiotech Receives New Patent!!!
Next Article
ISSCR 2022 Poster Presentation
Next Article
Scientific Poster from ATS: Respiratory Innovation Summit 2022
Next Article
ATS: Respiratory Innovation Summit 2022
Next Article
Medicinal Chemistry Strategy Meeting - 2022
Next Article
Health 2.0 - Presentation
Next Article
Health 2.0 Conference 2022
Next Article
Advanced Therapies Week: Phacilitate 2022
Next Article
SMSbiotech Welcome Beth Thompson-Webb to Board of Directors
Next Article
5th Meridian Clinical Trials Event
Next Article
SMSbiotech Successfully Completes First Test of a Series of Animal Studies for COPD Treatment
Next Article
SMSbiotech Announces Collaboration with Acculab Life Sciences
Next Article
SMSbiotech Selected for the ACSFall2021 Sci-Mix Event
Next Article
American Chemical Society Fall 2021 Presentation
Next Article
Nobel Laureate, Professor Luc Montagnier, Joins the SMSbiotech Advisory Board
Next Article
Small Mobile Stem Cells: Potential for Multi-Targeted Therapy of Emphysema in COPD - AASCP
Next Article
Prof. Peter D. Wagner, MD joins SMSbiotech on their Advisory Board
Next Article
SMSbiotech Completes Second Clinical Test for Chronic Non-Healing Wound Product
Next Article
In Vitro Gene Expression Study Demonstrates Small Mobile Stem Cells Stimulate Progenitor Lung Cells
Next Article
SMSbiotech Completes Clinical Test for Chronic Non-Healing Wound Product
Next Article
SMSbiotech Engages Exemplar Capital for Strategic Investment Banking Services
Next Article
MSC's In the Treatment of COVID-19
Next Article
Interviews with Dr. Roger Schechter: Episode 5: COVID-19 Part 2 (Effects and Solutions)
Next Article
Interviews with Dr. Roger Schechter EPISODE 4: COVID-19 Part 1
Next Article
Meet Abdulkader Rahmo, PhD.
Next Article
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 3: Angiogenesis and SMS Cells
Next Article
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 2: Accessibility of SMS Cells
Next Article
SMSbiotech Interviews with Dr. Roger Schechter EPISODE 1: Aging and Cell Therapy
Next Article
Ageing Hallmarks Exhibit Organ-Specific Temporal Signatures
Next Article
BioNeex Interview with SMSbiotech
Next Article
ACS National Meeting & Expo
Next Article
SMSbiotech Files Proposal with BARDA for a Covid-19 Treatment
Next Article
SAWC Spring | WHS
Next Article
Advanced Therapies Congress & Expo 2020
Next Article
Joe Kiani Becomes A Major Shareholder At SMSbiotech, Inc.
Next Article
SMSbiotech Introduces a New Product Website!
Next Article
ANGIOstream™ In Vitro Assay Fast Track Option – Inductive Niche Module (INM)
Next Article
Biotechnology Vendor Showcase™ – Southern California
Next Article
Biotechnology Vendor Showcase™ Events – Southern California
Next Article
Cell Symposia - Engineering Organoids and Organs
Next Article
ICancer 2019: 3rd International Cancer Conference And Expo
Next Article
20th Annual SoCalBio Conference
Next Article
SMSbiotech Obtains Patent
Next Article
Biocom Regenerative Medicine Fly-In – Washington DC
Next Article
New Facility Opens In San Marcos, CA
Next Article
Connector Series: SMSbiotech By Hai Truong (UCI)​
Next Article
SMSbiotech Celebrates Proof of Concept Victory!
Next Article
5th World Congress on Cell & Stem Cell Research, 2015
Next Article
2nd International Conference and Exhibition on Cell and Gene Therapy, 2013
Next Article
-

Recent blog posts

Dr. Joseph Loewenbein, M.D. Joins SMSbiotech as Scientific Advisor
Company News

Dr. Joseph Loewenbein, M.D. Joins SMSbiotech as Scientific Advisor

February 24, 2026
12th Annual World Patient Safety, Science & Technology Summit
Company News

12th Annual World Patient Safety, Science & Technology Summit

February 27, 2026
Joe Kiani Appointed Chairman of the Board at SMSbiotech
Company News

Joe Kiani Appointed Chairman of the Board at SMSbiotech

March 1, 2026